04:13 AM EDT, 03/16/2026 (MT Newswires) -- Harlan S Robins, Chief Scientific Officer, on March 11, 2026, sold 470,266 shares in Adaptive Biotechnologies ( ADPT ) for $6,193,403. Following the Form 4 filing with the SEC, Robins has control over a total of 1,522,058 common shares of the company, with 1,522,058 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000178085126000007/xslF345X05/form4.xml